1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    























































































































    A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas | American Journal of Neuroradiology  
    

















    





























    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      

  
      
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas
  
    	
A. Hilario, J.M. Sepulveda, A. Perez-Nuñez, E. Salvador, J.M. Millan, A. Hernandez-Lain, V. Rodriguez-Gonzalez, A. Lagares and A. Ramos

  
    	
American Journal of Neuroradiology June 2014,  35 (6) 1096-1102; DOI: https://doi.org/10.3174/ajnr.A3837 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Bondy  ML, 
    2. Scheurer  ME, 
    3. Malmer  B, 
    4. et al
    . Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium (BTEC). Cancer 2008;113:1953–68
    CrossRefPubMedWeb of Science
  2. 2.↵


    1. Jansen  M, 
    2. Yip  S, 
    3. Louis  DN
    . Molecular pathology in adult gliomas: diagnostic, prognostic and predictive markers. Lancet Neurol 2010;9:717–26
    CrossRefPubMedWeb of Science
  3. 3.↵


    1. Theeler  BJ, 
    2. Yung  WK, 
    3. Fuller  GN, 
    4. et al
    . Moving toward molecular classification of diffuse gliomas in adults. Neurology 2012;79:1917–26
    CrossRef
  4. 4.↵


    1. Labussiere  M, 
    2. Wang  XW, 
    3. Idbaih  A, 
    4. et al
    . Prognostic markers in gliomas. Future Oncol 2010;6:733–39
    CrossRefPubMed
  5. 5.↵


    1. Zacharaki  EI, 
    2. Morita  N, 
    3. Bhatt  P, 
    4. et al
    . Survival analysis of patients with high-grade gliomas based on data mining of imaging variables. AJNR Am J Neuroradiol 2012;33:1065–71
    Abstract/FREE Full Text
  6. 6.↵


    1. Ducray  F, 
    2. El Hallani  S, 
    3. Idbaih  A
    . Diagnostic and prognostic markers in gliomas. Curr Opin Oncol 2009;21:537–42
    CrossRefPubMed
  7. 7.↵


    1. Yan  H, 
    2. Parsons  DW, 
    3. Jin  G, 
    4. et al
    . IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009;360:765–73
    CrossRefPubMedWeb of Science
  8. 8.↵


    1. Hilario  A, 
    2. Ramos  A, 
    3. Perez-Nuñez  A, 
    4. et al
    . The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas. AJNR Am J Neuroradiol 2012;33:701–07
    Abstract/FREE Full Text
  9. 9.↵


    1. Caroline  I, 
    2. Rosenthal  MA
    . Imaging modalities in high-grade gliomas: pseudoprogression, recurrence, or necrosis? J Clin Neurosci 2012;19:633–37
    CrossRefPubMed
  10. 10.↵


    1. Louis  DN, 
    2. Ohgaki  H, 
    3. Wiestler  OD, 
    4. et al.
    , eds. 2007 WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon, France: IARC Press; 2007
  11. 11.↵


    1. Lacerda  S, 
    2. Law  M
    . Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin N Am 2009;19:527–57
    CrossRefPubMedWeb of Science
  12. 12.↵


    1. Wetzel  SG, 
    2. Cha  S, 
    3. Johnson  G, 
    4. et al
    . Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797–803
    CrossRefPubMedWeb of Science
  13. 13.↵


    1. Newson  R
    . Confidence intervals for rank statistics: Somers's D and extensions. Stata J 2006;6:308–34
  14. 14.↵


    1. Harrell  FE  Jr., 
    2. Lee  KL, 
    3. Mark  DB
    . Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361–87
    CrossRefPubMedWeb of Science
  15. 15.↵


    1. Hardesty  DA, 
    2. Sanai  N
    . The value of glioma extent of resection in the modern neurosurgical era. Front Neurol 2012;3:140–47
    PubMed
  16. 16.↵


    1. Law  M, 
    2. Yang  S, 
    3. Babb  JS, 
    4. et al
    . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55
    Abstract/FREE Full Text
  17. 17.↵


    1. Law  M, 
    2. Oh  S, 
    3. Babb  JS, 
    4. et al
    . Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging: prediction of patient clinical response. Radiology 2006;238:658–67
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. Law  M, 
    2. Young  RJ, 
    3. Babb  JA, 
    4. et al
    . Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490–98
    CrossRefPubMedWeb of Science
  19. 19.↵


    1. Boxerman  JL, 
    2. Prah  DE, 
    3. Paulson  ES, 
    4. et al
    . The role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol 2012;33:1081–87
    Abstract/FREE Full Text
  20. 20.↵


    1. Paulson  ES, 
    2. Schmainda  KM
    . Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008;249:601–13
    CrossRefPubMedWeb of Science
  21. 21.↵


    1. Law  M, 
    2. Young  R, 
    3. Babb  J, 
    4. et al
    . Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 2007;28:761–66
    Abstract/FREE Full Text
  22. 22.↵


    1. Saraswathy  S, 
    2. Crawford  FW, 
    3. Lamborn  KR, 
    4. et al
    . Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J Neurooncol 2009;91:69–81
    CrossRefPubMed
  23. 23.↵


    1. DeAngelis  LM
    . Brain tumors. N Engl J Med 2001;344:114–23
    CrossRefPubMedWeb of Science
  24. 24.↵


    1. Cha  S
    . Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475–87
    FREE Full Text
  25. 25.↵


    1. Kono  K, 
    2. Inoue  Y, 
    3. Nakayama  K, 
    4. et al
    . The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081–88
    Abstract/FREE Full Text
  26. 26.↵


    1. Sugahara  T, 
    2. Korogi  Y, 
    3. Kochi  M, 
    4. et al
    . Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53–60
    CrossRefPubMedWeb of Science
  27. 27.↵


    1. Hamstra  DA, 
    2. Chenevert  TL, 
    3. Moffat  BA, 
    4. et al
    . Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 2005;102:16759–64
    Abstract/FREE Full Text
  28. 28.↵


    1. Pope  WB, 
    2. Lai  A, 
    3. Mehta  R, 
    4. et al
    . Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol 2011;32:882–89
    Abstract/FREE Full Text
  29. 29.↵


    1. Pope  WB, 
    2. Qiao  XJ, 
    3. Kim  HJ, 
    4. et al
    . Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol 2012;108:491–98
    CrossRefPubMed
  30. 30.↵


    1. Hakyemez  B, 
    2. Erdogan  C, 
    3. Ercan  I, 
    4. et al
    . High-grade and low- grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005;60:493–502
    CrossRefPubMed
  31. 31.↵


    1. Sadeghi  N, 
    2. D'Haene  N, 
    3. Decaestecker  C, 
    4. et al
    . Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476–82
    Abstract/FREE Full Text
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas
  
    	
A. Hilario, J.M. Sepulveda, A. Perez-Nuñez, E. Salvador, J.M. Millan, A. Hernandez-Lain, V. Rodriguez-Gonzalez, A. Lagares, A. Ramos

  
    	
American Journal of Neuroradiology Jun 2014, 35 (6) 1096-1102; DOI: 10.3174/ajnr.A3837 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement